HCW Biologics Inc. - COM (HCWB)

CUSIP: 40423R105

Q4 2024 13F Holders as of 31 Dec 2024

Share change
+1,969,648
SEC-reported price per share
$0.45
Indexed holders
18
Value change
+$873,985
Number of buys
4
Number of sells
8

Security key

40423R105

Report period

Q4 2024

Indexed institutions

18

Top holders

10

Ownership snapshot

Top reported holders of HCWB - HCW Biologics Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Peter Rhode
Disclosed value leader
Peter Rhode
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5 13F Highest disclosed value: $161,061 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Peter Rhode has the largest disclosed position value at $161.1K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Peter Rhode's linked filing trail.
Disclosed position value Top 5
Peter Rhode $161.1K
Avantax Planning Partners, Inc. $150.8K
GEODE CAPITAL MANAGEMENT, LLC $98.9K
HighTower Advisors, LLC $98K
Jin-An Jiao $93.8K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Peter Rhode
3/4/5
Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations.
—
mixed-class rows
$161,061
136,354 shares
mixed-class rows
— 11 Dec 2023
Avantax Planning Partners, Inc.
13F
Company
13F
—
denominator unverified
$150,784
279,541 shares
— 30 Sep 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$98,874
183,259 shares
— 30 Sep 2024
HighTower Advisors, LLC
13F
Company
13F
—
denominator unverified
$98,000
180,810 shares
— 30 Sep 2024
Jin-An Jiao
3/4/5
VP of Development
—
mixed-class rows
$93,812
51,998 shares
mixed-class rows
— 31 May 2022
Cresset Asset Management, LLC
13F
Company
13F
—
denominator unverified
$71,195
131,990 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
18
Shares
3,128,731
Indexed holders
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 indexed holders
16
Q4 2024 indexed holders
18
Indexed holder difference
2
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .